Perfect Medical Announces Interim Results for FY2023/24 -November 24, 2023 at 05:07 am EST
— The Group’s revenue increased by 7.5% to
— The Group’s EBITDA increased by 5.4% to
— The Group’s net profit increased by 10.4% to
— The Board recommends the payment of an interim dividend of HK13.2 cents and a special dividend of HK1.0 cents per share to shareholders.
— The Group operated a total service area of 297,000 square feet in
For the period under review, the Group achieved satisfactory results thanks to the meaningful return of new customers and the solid relationship with the loyal customers in both
Hong Kong Operation
During the period, the Group witnessed a strong demand for its core aesthetic medical services thanks to the unwavering support by its loyal customers. The Group has recalibrated its business model to further expand its geographical reach in
At its non-aesthetic medical business, it includes a range of supplementary healthcare management services, including hair growth treatment, pain treatment, health screening service as well as other beauty and wellness services, to fully collaborate with our aesthetic medical services. During the period, the Group enhanced the cross-selling to the medical business following the improvement in our aesthetic medical business.
Revenue from regions outside
For the period under review, operating profit in mainland
As the demand generally bounced back after the three-year pandemic, the rebound in tourist arrivals in
For further information of the Group’s FY2023/24 interim results, please refer to the Company’s Interim Results Announcement on the
For further information, please contact:
Marco So /
Tel: (852) 2770 2099
Tel: (852) 2136 6185
Copyright 2023 ACN Newswire . All rights reserved.
© Japan Corporate News, source